According to a recent study by Indian-American scientists, monkeypox mutations have enabled the virus to grow stronger and smarter, evading antiviral drugs and vaccines in its mission to infect more people. 

The virus has infected more than 77,000 people in more than 100 countries, and in recent times, the case fatality ratio has been around 3e6 per cent, according to the World Health Organization (WHO).

The findings of the study, published in the Journal of Autoimmunity, can help in modifying the existing drugs used to treat monkeypox or developing new medicines that can counter the mutations thus reducing symptoms of the disease and curbing the spread of the virus.